CN1105588A - Anticancer traditional Chinese medicine "Bisikang" capsule and its preparation method - Google Patents
Anticancer traditional Chinese medicine "Bisikang" capsule and its preparation method Download PDFInfo
- Publication number
- CN1105588A CN1105588A CN 94113805 CN94113805A CN1105588A CN 1105588 A CN1105588 A CN 1105588A CN 94113805 CN94113805 CN 94113805 CN 94113805 A CN94113805 A CN 94113805A CN 1105588 A CN1105588 A CN 1105588A
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- capsule
- scutellariae
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 239000002775 capsule Substances 0.000 title claims abstract description 18
- 230000001093 anti-cancer Effects 0.000 title abstract description 4
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 241000208340 Araliaceae Species 0.000 claims abstract description 12
- 241000222336 Ganoderma Species 0.000 claims abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 12
- 241001250596 Pleione Species 0.000 claims abstract description 12
- 235000008434 ginseng Nutrition 0.000 claims abstract description 12
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 11
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 11
- 229940126678 chinese medicines Drugs 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 15
- 239000009636 Huang Qi Substances 0.000 claims description 11
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 11
- 240000000599 Lentinula edodes Species 0.000 claims description 11
- 235000001715 Lentinula edodes Nutrition 0.000 claims description 11
- 244000293323 Cosmos caudatus Species 0.000 claims description 10
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 10
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 10
- 239000009969 fructus bruceae Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 2
- 244000306301 Caesalpinia sappan Species 0.000 abstract 2
- 235000015162 Caesalpinia sappan Nutrition 0.000 abstract 2
- 241000402754 Erythranthe moschata Species 0.000 abstract 2
- 244000097577 Rhus javanica Species 0.000 abstract 2
- 235000010889 Rhus javanica Nutrition 0.000 abstract 2
- 241000207929 Scutellaria Species 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 abstract 1
- 241000244987 Daiswa polyphylla Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 abstract 1
- 241000612166 Lysimachia Species 0.000 abstract 1
- 241000157511 Oldenlandia Species 0.000 abstract 1
- 241001404789 Smilax glabra Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 240000007284 Stenochlaena palustris Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 229940097275 indigo Drugs 0.000 abstract 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 4
- 229910052788 barium Inorganic materials 0.000 description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000009333 tian-xian Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to an anticancer Chinese medicine Bisikang capsule for curing malignant tumor and its preparation method. Said invention consists of ginseng, synthetic cow-bezoare, notogensing, musk, pearl, paris polyphylla, astragalus root, flavescent sophora root, lucid ganoderma, mushroom, smilax glabra rhizome, lysimachia, rhizoma and root of Sixangular Drsosma, barbat skullcap, Chinese sage, oldenlandia, scutellaria root, liquorice, pleione rhizome, natural indigo, climbing fern spore, fruit of Java Brucea and sappan wood. Its preparation method is as follows: except for ginseng, notoginseng, synthetic cow-bezoare, musk, pearl, fruit of Java Brucea and sappan wood, rest 16 Chinese medicines are decocted, concentrated and dried into clear paste, and then the paste and the above-mentioned medicines are pulverized and placed in capsule, and its effective rate is 83.48%.
Description
The present invention relates to a kind of Chinese medicine medicine for preventing " Bisikang " capsule and manufacture method thereof for the treatment of malignant tumor.(must grant health former famous-brand and high-quality good fortune health)
Malignant tumor accounts for first place (rural area occupies second), serious harm human life health China's sickness rate height, mortality rate town dweller in all kinds of causes of the death.Because when finding is middle and advanced stage more than 80%, promptly lose surgical radical treatment opportunity, also limited effective application of radiotherapy chemotherapy.Traditional Chinese medical herbal treatment is disliked the history of giving birth to the existing two thousand years of tumor, accumulated abundant theory and practice experience, to relief of symptoms, improve body constitution, improve life quality, prolong existence and have sure effect, be subjected to generally paying attention to, be acknowledged as one of main Therapeutic Method of middle and advanced stage patient.Chinese medicine compound TIANXIAN WAN as the development of institute of materia medica, anticancer association Changbai Mountain, Jilin Province is exactly a kind of cancer therapy drug with heat reliving and toxin-eliminating, blood stasis-eliminating and stagnation-dissipating, invigorating the spleen and regulating the stomach, benefiting qi and nourishing blood, it mainly has certain curative effect to alimentary tract cancer, and is also not high to other cancer curative effect.
The purpose of this invention is to provide a kind of Chinese medicine medicine for preventing " Bisikang " capsule and manufacture method thereof for the treatment of malignant tumor.
Purpose of the present invention can reach by following measure:
A kind of Chinese medicine medicine for preventing " Bisikang " capsule is by Radix Ginseng; the artificial Calculus Bovis; Radix Notoginseng; Moschus; Margarita; the flea body; the Radix Astragali; Radix Sophorae Flavescentis; Ganoderma; Lentinus Edodes; Rhizoma Smilacis Glabrae; Herba Lysimachiae; Radix et Rhizoma Dysosmatis; Herba Scutellariae Barbatae; Herba Salviae Chinensis; Herba Hedyotidis Diffusae; Radix Scutellariae; Radix Glycyrrhizae; Pseudobulbus Cremastrae Seu Pleiones; Indigo Naturalis; Spora Lygodii; crow dawn and Lignum Sappan are formed; count by weight: Radix Ginseng 40-60; artificial Calculus Bovis 8-14; Radix Notoginseng 40-60; Moschus 3-6, Margarita 8-14, flea body 25-45; Radix Astragali 25-45; Radix Sophorae Flavescentis 25-45, Ganoderma 8-15, Lentinus Edodes 10-30; Rhizoma Smilacis Glabrae 10-30; Herba Lysimachiae 40-75, Radix et Rhizoma Dysosmatis 8-12, Herba Scutellariae Barbatae 25-45; Herba Salviae Chinensis 15-21; Herba Hedyotidis Diffusae 18-25, Radix Scutellariae 10-15, Radix Glycyrrhizae 8-12; Pseudobulbus Cremastrae Seu Pleiones 6-14; Indigo Naturalis 35-55, Spora Lygodii 13-18, sub-25-35 of crow dawn and Lignum Sappan 25-35; remove Radix Ginseng; Radix Notoginseng; the artificial Calculus Bovis; Moschus; Margarita; outside crow dawn and the Lignum Sappan, the weight of ten Six-element Chinese medicines such as all the other flea bodies is the weight after concentrating.
The manufacture method of Chinese medicine medicine for preventing " Bisikang " capsule:
(1) gets the flea body, the Radix Astragali, Radix Sophorae Flavescentis, Ganoderma, Lentinus Edodes, Rhizoma Smilacis Glabrae, Herba Lysimachiae, Radix et Rhizoma Dysosmatis, Herba Scutellariae Barbatae, Herba Salviae Chinensis, Herba Hedyotidis Diffusae, Radix Scutellariae, Radix Glycyrrhizae, Pseudobulbus Cremastrae Seu Pleiones, Indigo Naturalis, each 10kg of Spora Lygodii, decoct with water respectively, filtrate is respectively distinguished the flavor of into the 200-300 gram after concentrating oven dry, connect the weight portion score and do not get the clear paste that concentrates after drying: flea body 25-45, Radix Astragali 25-45, Radix Sophorae Flavescentis 25-45, Ganoderma 8-15, Lentinus Edodes 10-30, Rhizoma Smilacis Glabrae 10-30, Herba Lysimachiae 40-75, Radix et Rhizoma Dysosmatis 8-12, Herba Scutellariae Barbatae 25-45, Herba Salviae Chinensis 15-21, Herba Hedyotidis Diffusae 18-25, Radix Scutellariae 10-15, Radix Glycyrrhizae 8-12, Pseudobulbus Cremastrae Seu Pleiones 6-14, Indigo Naturalis 35-55 and Spora Lygodii 13-18, bake out temperature 80-90 ℃, time 47-49 hour.
(2) get Radix Ginseng 40-60 by weight; artificial Calculus Bovis 8-14; Radix Notoginseng 40-60; Moschus 3-6 and Lignum Sappan 25-35 pulverize separately are crossed 80 mesh sieves; Margarita water flies into fine powder and crosses 120 mesh sieves; then crow dawn is extracted Oleum Fructus Bruceae 25-30, above medicated powder and Oleum Fructus Bruceae mix homogeneously are crossed 120 mesh sieves.
(3) with standby above-mentioned clear paste with cross 120 purpose Chinese medicine powder bedding-ins, during the 120 order mixings that sieve were encapsulated, each capsule powder charge powder 250mg packaged after cobalt 60 gamma-rays sterilizations.
Be described in further detail below by embodiment:
The prescription of " Bisikang " capsule is: Radix Ginseng 50g, artificial Calculus Bovis 10g, Radix Notoginseng 50g, Moschus 5g; Margarita 10g, Lignum Sappan 30g is below for concentrating the clear paste weight after drying: flea body 30g, Radix Astragali 30g; Radix Sophorae Flavescentis 15g, Ganoderma 12g, Lentinus Edodes 15g, Rhizoma Smilacis Glabrae 15g; Herba Lysimachiae 60g, Radix et Rhizoma Dysosmatis 10g, Herba Scutellariae Barbatae 30g, Herba Salviae Chinensis 18g; Herba Hedyotidis Diffusae 20g, Radix Scutellariae 12g, Radix Glycyrrhizae 10g, Pseudobulbus Cremastrae Seu Pleiones 9g; Indigo Naturalis 50g, Spora Lygodii 15g, the crow dawn, sub-30g fluid was formed.
Manufacture method:
(1) gets the flea body, the Radix Astragali, Radix Sophorae Flavescentis, Ganoderma, Lentinus Edodes, Rhizoma Smilacis Glabrae, Herba Lysimachiae, Radix et Rhizoma Dysosmatis, Herba Scutellariae Barbatae, Herba Salviae Chinensis, Herba Hedyotidis Diffusae, Radix Scutellariae, Radix Glycyrrhizae, Pseudobulbus Cremastrae Seu Pleiones, Indigo Naturalis, each 10kg of Spora Lygodii forms, decoct with water respectively, filtrate is respectively distinguished the flavor of into the 200-300 gram after concentrating oven dry, qinghuo reagent again: flea body 30g, Radix Astragali 30g, Radix Sophorae Flavescentis 15g, Ganoderma 12g, Lentinus Edodes 15g, Rhizoma Smilacis Glabrae 15g, Herba Lysimachiae 60g, Radix et Rhizoma Dysosmatis 10g, Herba Scutellariae Barbatae 30g, Herba Salviae Chinensis 18g, Herba Hedyotidis Diffusae 20g, Radix Scutellariae 12g, Radix Glycyrrhizae 10g, Pseudobulbus Cremastrae Seu Pleiones 9g, Indigo Naturalis 50g, Spora Lygodii 15g, bake out temperature 80-90 ℃, time 47-49 hour;
(2) get Radix Ginseng 50g, artificial Calculus Bovis 10g, Radix Notoginseng 50g; Moschus 5g, Lignum Sappan 30g pulverize separately is crossed 80 mesh sieves, and Margarita 10g water flew 120 purpose fine powders; then crow dawn is extracted Oleum Fructus Bruceae 30g, above medicated powder and Oleum Fructus Bruceae mix homogeneously are crossed 120 mesh sieves.
(3) with standby above-mentioned clear paste with cross 120 purpose Chinese medicine powder bedding-ins, behind 120 orders that sieve mix homogeneously encapsulated in, each capsule powder charge powder 250mg packages after cobalt 60 gamma-rays sterilizations.
Usage of the present invention, consumption and the course of treatment:
3 times/day, each 750mg-1000g, 30 days is a course of treatment, 90 days is one-period.
Advantage of the present invention:
" Bisikang " capsule proves through the zoopery of Tianjin medical science institute: this medical instrument has significant antitumaous effect, and its tumor inhibition effect can reach 43.8%.
Clinical experiment is by Tianjin second central hospital, Shanxi Province Tumor Hospital, People's Hospital of Shanxi Prov., first Affiliated Hospital of Shanxi Medical College, Taiyuan City central hospital, Shanxi Province Affiliated Hospital of The Medical College of Changzhi, Shanxi and Beijing, hospitalize such as Henan and Hebei malignant tumor 666 examples, all case is all made a definite diagnosis through pathology or cytodiagnosis, list is treated the esophageal carcinoma with " Bisikang " capsule, pulmonary carcinoma, the total effective rate of malignant tumor such as bladder cancer is 83.48%, this medicine cooperates to be put, chemotherapy and operative treatment can improve patient's clinical symptoms, improve patient's immunity and prolong its life cycle, this medicine is not found obvious toxic and side effects.This medicine applied range, and usage is easy, extensively there is the excellent popularization using value in the medicine source.Hentriaconta-day in August, 1993 is identified by Shanxi Province Science and Technology Commission.
Model case:
Open * *, the woman, 59 years old, Shanxi Xinzhou City people, the main cause feed is sent out and is sprayed May, can eat semi-fluid, and there is the 7cm filling defect in the esophagogram stage casing, radiotherapy DT7000, CG
4After can eat soft general food, canel barium meal contrast examination passes through, it is poor to expand, mucosa light, but local recurrence after 13 months, can only influent stream matter with chest pain, take " Bisikang " capsule and can eat general food after two months, canel barium meal contrast examination by still can, it is poor to expand, logotype " Bisikang " capsule 4 courses of treatment after 15 months, life-saving recurred after 2 years.
Claims (2)
1; a kind of Chinese medicine medicine for preventing " Bisikang " capsule; it is characterized in that by Radix Ginseng; the artificial Calculus Bovis; Radix Notoginseng; Moschus; Margarita; the flea body; the Radix Astragali; Radix Sophorae Flavescentis; Ganoderma; Lentinus Edodes; Rhizoma Smilacis Glabrae; Herba Lysimachiae; Radix et Rhizoma Dysosmatis; Herba Scutellariae Barbatae; Herba Salviae Chinensis; Herba Hedyotidis Diffusae; Radix Scutellariae; Radix Glycyrrhizae; Pseudobulbus Cremastrae Seu Pleiones; Indigo Naturalis; Spora Lygodii; crow dawn and Lignum Sappan are formed; count by weight: Radix Ginseng 40-60; artificial Calculus Bovis 8-14; Radix Notoginseng 40-60; Moschus 3-6, Margarita 8-14, flea body 25-45; Radix Astragali 25-45; Radix Sophorae Flavescentis 25-45, Ganoderma 8-15, Lentinus Edodes 10-30; Rhizoma Smilacis Glabrae 10-30; Herba Lysimachiae 40-75, Radix et Rhizoma Dysosmatis 8-12, Herba Scutellariae Barbatae 25-45; Herba Salviae Chinensis 15-21; Herba Hedyotidis Diffusae 18-25, Radix Scutellariae 10-15, Radix Glycyrrhizae 8-12; Pseudobulbus Cremastrae Seu Pleiones 6-14; Indigo Naturalis 35-55, Spora Lygodii 13-18, sub-25-35 of crow dawn and Lignum Sappan 25-35; remove Radix Ginseng; Radix Notoginseng; the artificial Calculus Bovis; Moschus; Margarita; outside crow dawn and the Lignum Sappan, the weight of ten Six-element Chinese medicines such as all the other flea bodies is for concentrating the weight after drying.
2, the manufacture method of the described Chinese medicine medicine for preventing " Bisikang " capsule of claim 1:
(1) gets the flea body, the Radix Astragali, Radix Sophorae Flavescentis, Ganoderma, Lentinus Edodes, Rhizoma Smilacis Glabrae, Herba Lysimachiae, Radix et Rhizoma Dysosmatis, Herba Scutellariae Barbatae, Herba Salviae Chinensis, Herba Hedyotidis Diffusae, Radix Scutellariae, Radix Glycyrrhizae, Pseudobulbus Cremastrae Seu Pleiones, Indigo Naturalis, each 10kg of Spora Lygodii, decoct with water respectively, filtrate is respectively distinguished the flavor of into the 200-300 gram after concentrating oven dry, connect the weight portion score and do not get the clear paste that concentrates after drying: flea body 25-45, Radix Astragali 25-45, Radix Sophorae Flavescentis 25-45, Ganoderma 8-15, Lentinus Edodes 10-30, Rhizoma Smilacis Glabrae 10-30, Herba Lysimachiae 40-75, Radix et Rhizoma Dysosmatis 8-12, Herba Scutellariae Barbatae 25-45, Herba Salviae Chinensis 15-21, Herba Hedyotidis Diffusae 18-25, Radix Scutellariae 10-15, Radix Glycyrrhizae 8-12, Pseudobulbus Cremastrae Seu Pleiones 6-14, Indigo Naturalis 35-55 and Spora Lygodii 13-18, bake out temperature 80-90 ℃, time 47-49 hour;
(2) get Radix Ginseng 40-60 by weight, artificial Calculus Bovis 8-14, Radix Notoginseng 40-60, Moschus 3-6 and Lignum Sappan 25-35 pulverize separately are crossed 80 mesh sieves, Margarita water flies into fine powder and crosses 120 mesh sieves, then crow dawn is extracted Oleum Fructus Bruceae 25-30, above medicated powder and Oleum Fructus Bruceae mix homogeneously are crossed 120 mesh sieves;
(3) with standby above-mentioned clear paste with cross 120 purpose Chinese medicine powder bedding-ins, during the 120 order mixings that sieve were encapsulated, each capsule powder charge powder 250mg packaged after cobalt 60 gamma-rays sterilizations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94113805 CN1105588A (en) | 1994-11-02 | 1994-11-02 | Anticancer traditional Chinese medicine "Bisikang" capsule and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94113805 CN1105588A (en) | 1994-11-02 | 1994-11-02 | Anticancer traditional Chinese medicine "Bisikang" capsule and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1105588A true CN1105588A (en) | 1995-07-26 |
Family
ID=5036824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 94113805 Pending CN1105588A (en) | 1994-11-02 | 1994-11-02 | Anticancer traditional Chinese medicine "Bisikang" capsule and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1105588A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000027411A1 (en) * | 1998-11-11 | 2000-05-18 | Liou Tchin | Composition made of plant extracts, especially for use in cancer treatment |
| CN1062168C (en) * | 1997-05-26 | 2001-02-21 | 陈本洪 | Medicine for eliminating toxicity and side-effect casused by chemotherapy during treating cancer |
| CN1063648C (en) * | 1997-12-22 | 2001-03-28 | 邓恺 | Medical preparation for tumour |
| EP1626729A4 (en) * | 2003-05-29 | 2006-08-16 | Bio Defense Nutritionals Inc | Compositions and methods for symptomatic relief |
| CN101822711A (en) * | 2010-05-22 | 2010-09-08 | 山西省肿瘤医院 | Preparation method of traditional Chinese medicine perfusate and application |
| CN101904892A (en) * | 2010-05-22 | 2010-12-08 | 山西省肿瘤医院 | Preparation process for Sappan Wood extract perfusate and application thereof in treating bladder cancer |
| US8173177B2 (en) | 2003-09-08 | 2012-05-08 | Genyous Biomed International Inc. | Compositions of botanical extracts for cancer therapy |
| CN102579916A (en) * | 2012-03-16 | 2012-07-18 | 范冬锁 | Capsules for treating respiratory tract and digestive tract cancers and preparation method thereof |
| CN103520511A (en) * | 2013-10-25 | 2014-01-22 | 刘芙芸 | Traditional Chinese medicine for treatment of blood-stagnation and phlegm-coagulation type thyroid adenomas and preparation method thereof |
| CN108434304A (en) * | 2018-05-23 | 2018-08-24 | 北京雄九医学研究院 | The preparation method of cancer-resisting Chinese medicine |
-
1994
- 1994-11-02 CN CN 94113805 patent/CN1105588A/en active Pending
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1062168C (en) * | 1997-05-26 | 2001-02-21 | 陈本洪 | Medicine for eliminating toxicity and side-effect casused by chemotherapy during treating cancer |
| CN1063648C (en) * | 1997-12-22 | 2001-03-28 | 邓恺 | Medical preparation for tumour |
| WO2000027411A1 (en) * | 1998-11-11 | 2000-05-18 | Liou Tchin | Composition made of plant extracts, especially for use in cancer treatment |
| EP1626729A4 (en) * | 2003-05-29 | 2006-08-16 | Bio Defense Nutritionals Inc | Compositions and methods for symptomatic relief |
| US8173177B2 (en) | 2003-09-08 | 2012-05-08 | Genyous Biomed International Inc. | Compositions of botanical extracts for cancer therapy |
| US20130101616A1 (en) * | 2003-09-08 | 2013-04-25 | James Dao | Compositions of botanical extracts for cancer therapy |
| CN101822711A (en) * | 2010-05-22 | 2010-09-08 | 山西省肿瘤医院 | Preparation method of traditional Chinese medicine perfusate and application |
| CN101904892A (en) * | 2010-05-22 | 2010-12-08 | 山西省肿瘤医院 | Preparation process for Sappan Wood extract perfusate and application thereof in treating bladder cancer |
| CN101904892B (en) * | 2010-05-22 | 2012-06-06 | 山西省肿瘤医院 | Preparation process for Sappan Wood extract perfusate and application thereof in treating bladder cancer |
| CN102579916A (en) * | 2012-03-16 | 2012-07-18 | 范冬锁 | Capsules for treating respiratory tract and digestive tract cancers and preparation method thereof |
| CN103520511A (en) * | 2013-10-25 | 2014-01-22 | 刘芙芸 | Traditional Chinese medicine for treatment of blood-stagnation and phlegm-coagulation type thyroid adenomas and preparation method thereof |
| CN108434304A (en) * | 2018-05-23 | 2018-08-24 | 北京雄九医学研究院 | The preparation method of cancer-resisting Chinese medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1330347C (en) | Gongbu ointment | |
| CN101057946B (en) | Traditional Chinese medicine for treating heart disease | |
| CN103768398B (en) | Traditional Chinese medicine composition for treating advanced lung tumors | |
| CN1105588A (en) | Anticancer traditional Chinese medicine "Bisikang" capsule and its preparation method | |
| CN101069733A (en) | Medicine for treating viral myocarditis and cardiac muscle diseases | |
| CN110694044A (en) | A Chinese medicinal composition and its preparation method | |
| CN106728694A (en) | A kind of tumor post-operation patients ' recovery Chinese medicine preparation and preparation method thereof | |
| CN111617206A (en) | Plant preparation composition for treating lung cancer and preparation method and using method thereof | |
| CN112717081A (en) | Blood-activating face-beautifying cream formula and application thereof | |
| CN102552748A (en) | Traditional Chinese medicine capable of maintaining beauty and keeping young | |
| CN102671160A (en) | Traditional Chinese medicine decoction for treating edema and preparation method of traditional Chinese medicine decoction | |
| CN108704040B (en) | Traditional Chinese medicine composition and application thereof | |
| CN105343578A (en) | Medicine composition for treating haemorrhoids | |
| CN105412621A (en) | Method for preparing pharmaceutical composition for treating hemorrhoids | |
| CN113812614A (en) | Uric acid resistant functional food | |
| CN104998005A (en) | Traditional Chinese medicine oral liquid special for treating constipation and preparation method thereof | |
| CN115531488B (en) | Composition for soothing liver and strengthening spleen and being used for postoperative adjuvant therapy of breast cancer and preparation method thereof | |
| CN109646592A (en) | It is a kind of suitable for irritable cough and the Chinese medicine composition and Chinese materia medica preparation of acute and chronic pharyngitis | |
| CN103638301B (en) | A kind of Chinese medicine of building up resistance and manufacture method | |
| CN111388564B (en) | Traditional Chinese medicine for treating bradyarrhythmia | |
| CN107661391A (en) | Treat Yao nationality medicine external preparation of the proliferation of mammary gland and preparation method thereof | |
| CN1238035C (en) | Method for treating tuberculosis and its preparing process | |
| CN114949136A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method and application thereof | |
| CN116920045A (en) | Antitumor composition and preparation method and application thereof | |
| CN118987113A (en) | Medicated diet for improving immunity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |